Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Drug Safety
|
July 6, 2016
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
Linda Härmark, June Raine, Hubert Leufkens, et al.
Drug Safety
|
November 11, 2017
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
Giampiero Mazzaglia, Sabine M J Straus, Peter Arlett, et al.
Drug Safety
|
November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies
Ineke Crijns, Sabine Straus, Michiel Luteijn, et al.
Nature Reviews. Drug Discovery
|
April 23, 2014
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee
Peter Arlett, Geraldine Portier, Roberto de Lisa, et al.
Nature Reviews. Drug Discovery
|
November 16, 2013
The risks of risk aversion in drug regulation
Hans-Georg Eichler, Brigitte Bloechl-Daum, Daniel Brasseur, et al.
Clinical Pharmacology and Therapeutics
|
February 22, 2021
Assuring Access to Safe Medicines in Pregnancy and Breastfeeding
Janet Nooney, Shannon Thor, Corinne de Vries, et al.
Drug Safety
|
August 22, 2018
Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action
Anna Radecka, Louise Loughlin, Mick Foy, et al.
Drug Safety
|
December 20, 2018
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives
Janet Sultana, Ugo Moretti, Antonio Addis, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Drug Safety
|
July 6, 2016
Patient-Reported Safety Information: A Renaissance of Pharmacovigilance?
Linda Härmark, June Raine, Hubert Leufkens, et al.
Drug Safety
|
November 11, 2017
Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs
Giampiero Mazzaglia, Sabine M J Straus, Peter Arlett, et al.
Drug Safety
|
November 5, 2011
Implementation of the harmonized EU isotretinoin Pregnancy Prevention Programme: a questionnaire survey among European regulatory agencies
Ineke Crijns, Sabine Straus, Michiel Luteijn, et al.
Nature Reviews. Drug Discovery
|
April 23, 2014
Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee
Peter Arlett, Geraldine Portier, Roberto de Lisa, et al.
Nature Reviews. Drug Discovery
|
November 16, 2013
The risks of risk aversion in drug regulation
Hans-Georg Eichler, Brigitte Bloechl-Daum, Daniel Brasseur, et al.
Clinical Pharmacology and Therapeutics
|
February 22, 2021
Assuring Access to Safe Medicines in Pregnancy and Breastfeeding
Janet Nooney, Shannon Thor, Corinne de Vries, et al.
Drug Safety
|
August 22, 2018
Enhancing Pharmacovigilance Capabilities in the EU Regulatory Network: The SCOPE Joint Action
Anna Radecka, Louise Loughlin, Mick Foy, et al.
Drug Safety
|
December 20, 2018
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives
Janet Sultana, Ugo Moretti, Antonio Addis, et al.
Page
of 2